[go: up one dir, main page]

WO2000073343A3 - Nouvelles utilisations d'anticorps contre la douleur et peptides associes - Google Patents

Nouvelles utilisations d'anticorps contre la douleur et peptides associes Download PDF

Info

Publication number
WO2000073343A3
WO2000073343A3 PCT/IL2000/000312 IL0000312W WO0073343A3 WO 2000073343 A3 WO2000073343 A3 WO 2000073343A3 IL 0000312 W IL0000312 W IL 0000312W WO 0073343 A3 WO0073343 A3 WO 0073343A3
Authority
WO
WIPO (PCT)
Prior art keywords
acetylcholinesterase
antibodies against
diagnostic uses
terminal peptides
against acetylcholinesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2000/000312
Other languages
English (en)
Other versions
WO2000073343A2 (fr
Inventor
Hermona Soreq
Daniela Kaufer
Alon Friedman
Shlomo Seidman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE60018279T priority Critical patent/DE60018279T2/de
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Priority to DK00931517T priority patent/DK1187853T3/da
Priority to US09/980,263 priority patent/US7063948B1/en
Priority to IL14685000A priority patent/IL146850A0/xx
Priority to EP00931517A priority patent/EP1187853B1/fr
Priority to CA2371675A priority patent/CA2371675C/fr
Priority to AU49465/00A priority patent/AU4946500A/en
Priority to AT00931517T priority patent/ATE289612T1/de
Publication of WO2000073343A2 publication Critical patent/WO2000073343A2/fr
Publication of WO2000073343A3 publication Critical patent/WO2000073343A3/fr
Anticipated expiration legal-status Critical
Priority to US11/352,073 priority patent/US20060121536A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des anticorps reconnaissant l'acétylcholinestérase ou un peptide C-terminal dérivé de l'acétylcholinestérase, utiles dans le diagnostic du stress du système nerveux central (SNC), de niveaux élevés de glucocorticoïdes, d'un dérèglement de la barrière hémato-encéphalique ou de la maladie d'Alzheimer. L'invention concerne également des techniques de diagnostic du stress du système nerveux central (SNC), de niveaux élevés de glucocorticoïdes ou d'un dérèglement de la barrière hémato-encéphalique chez un mammifère, utilisant les anticorps de l'invention.
PCT/IL2000/000312 1999-05-31 2000-05-31 Nouvelles utilisations d'anticorps contre la douleur et peptides associes Ceased WO2000073343A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AT00931517T ATE289612T1 (de) 1999-05-31 2000-05-31 Diagnostische verwendungen von gegen acetylcholinesterase oder deren c-terminale peptide gerichteten antikörpern
DK00931517T DK1187853T3 (da) 1999-05-31 2000-05-31 Diagnostiske anvendelser af antistoffer mod acetylcholinesterase eller C-terminale peptider deraf
US09/980,263 US7063948B1 (en) 1999-05-31 2000-05-31 Uses of antibodies against AChE and peptides thereof
IL14685000A IL146850A0 (en) 1999-05-31 2000-05-31 Novel uses of antibodies against ache and peptides thereof
EP00931517A EP1187853B1 (fr) 1999-05-31 2000-05-31 Nouvelles utilisations diagnostiques d'anticorps diriges contre l'acetylcholinesterase ou ses peptides c-terminaux
DE60018279T DE60018279T2 (de) 1999-05-31 2000-05-31 Diagnostische verwendungen von gegen acetylcholinesterase oder deren c-terminale peptide gerichteten antikörpern
AU49465/00A AU4946500A (en) 1999-05-31 2000-05-31 Novel uses of antibodies against ache and peptides thereof
CA2371675A CA2371675C (fr) 1999-05-31 2000-05-31 Nouvelles utilisations d'anticorps contre la douleur et peptides associes
US11/352,073 US20060121536A1 (en) 1999-05-31 2006-02-10 Novel uses of antibodies against AChE and peptides thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13022599A IL130225A0 (en) 1999-05-31 1999-05-31 Novel uses of antibodies against ache and peptides thereof
IL130225 1999-05-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/352,073 Division US20060121536A1 (en) 1999-05-31 2006-02-10 Novel uses of antibodies against AChE and peptides thereof

Publications (2)

Publication Number Publication Date
WO2000073343A2 WO2000073343A2 (fr) 2000-12-07
WO2000073343A3 true WO2000073343A3 (fr) 2001-01-18

Family

ID=11072864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2000/000312 Ceased WO2000073343A2 (fr) 1999-05-31 2000-05-31 Nouvelles utilisations d'anticorps contre la douleur et peptides associes

Country Status (9)

Country Link
US (1) US7063948B1 (fr)
EP (1) EP1187853B1 (fr)
AT (1) ATE289612T1 (fr)
AU (1) AU4946500A (fr)
CA (1) CA2371675C (fr)
DE (1) DE60018279T2 (fr)
ES (1) ES2238282T3 (fr)
IL (1) IL130225A0 (fr)
WO (1) WO2000073343A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US8954149B2 (en) 2004-02-20 2015-02-10 Brainsgate Ltd. External stimulation of the SPG
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131707A0 (en) * 1999-05-31 2001-03-19 Yissum Res Dev Co Acetylcholinesterase-derived peptides and uses thereof
US7684859B2 (en) 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
EP1585430B1 (fr) 2002-11-14 2017-01-11 Brainsgate Ltd. Outils chirurgicaux et techniques de stimulation
GB0708646D0 (en) * 2007-05-04 2007-06-13 Enkephala Ltd Biologically active C-terminal fragment of acetylcholinesterase
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
EP2878335B1 (fr) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant et système d'implantation pour stimulateur neural
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022132A1 (fr) * 1996-11-20 1998-05-28 Yissum Res Dev Co Methode et composition permettant le passage a travers la barriere hemato-encephalique
WO1999015695A1 (fr) * 1997-09-24 1999-04-01 The University Of Melbourne Analyse permettant de diagnostiquer la maladie d'alzheimer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (fr) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Récepteurs chimériques par liaison et expression de l'ADN
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング　インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
DE4002897A1 (de) 1990-02-01 1991-08-08 Behringwerke Ag Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken")
GB9606040D0 (en) * 1996-03-22 1996-05-22 Isis Innovation Active peptide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022132A1 (fr) * 1996-11-20 1998-05-28 Yissum Res Dev Co Methode et composition permettant le passage a travers la barriere hemato-encephalique
WO1999015695A1 (fr) * 1997-09-24 1999-04-01 The University Of Melbourne Analyse permettant de diagnostiquer la maladie d'alzheimer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOSCHETTI, NICOLA ET AL: "Monoclonal antibodies against a C-terminal peptide of human brain acetylcholinesterase distinguish between erythrocyte and brain acetylcholinesterases.", CLINICAL CHEMISTRY, (1996) VOL. 42, NO. 1, PP. 19-23., XP000943177 *
LOFT A G: "Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.", DANISH MEDICAL BULLETIN, (1995 FEB) 42 (1) 54-70. REF: 138, XP000943169 *
MADER M ET AL: "Neuronal acetylcholinesterase levels in cerebrospinal fluid and serum determined by a specific and sensitive immunoassay.", EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, (1991 JAN) 29 (1) 51-5., XP000943191 *
NOVALES-LI, PHILLIP ET AL: "Isolation of human acetylcholinesterase from post-mortem brain tissue samples of Alzheimer 's disease patients and the production of monoclonal antibodies", PHILIPP. J. SCI. (1995), 124(1), 39-51, XP000943137 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US8954149B2 (en) 2004-02-20 2015-02-10 Brainsgate Ltd. External stimulation of the SPG
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation

Also Published As

Publication number Publication date
IL130225A0 (en) 2000-06-01
WO2000073343A2 (fr) 2000-12-07
ES2238282T3 (es) 2005-09-01
US7063948B1 (en) 2006-06-20
CA2371675A1 (fr) 2000-12-07
DE60018279D1 (de) 2005-03-31
AU4946500A (en) 2000-12-18
CA2371675C (fr) 2010-01-26
ATE289612T1 (de) 2005-03-15
EP1187853B1 (fr) 2005-02-23
EP1187853A2 (fr) 2002-03-20
DE60018279T2 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
WO2000073343A3 (fr) Nouvelles utilisations d'anticorps contre la douleur et peptides associes
EP0911390A3 (fr) Protéine kinases comme outils pour le diagnostic et le traitement de la maladie d' Alzheimer
WO2001087354A3 (fr) Utilisation de radioligands a petites molecules en vue de rechercher des inhibiteurs de production d'amyloide-beta et destine a l'imagerie diagnostique
WO2001058916A3 (fr) Recepteur hdgnr10 de la chimiokine de la proteine g humaine (ccr5)
AU2002237296A1 (en) Conformationally abnormal forms of tau proteins and specific antibodies thereto
EP1990409A3 (fr) Bactériophage
WO1998017796A3 (fr) Procede et compositions pour inhiber des inflammations et des angiogeneses comprenant une sous-unite de cd97 alpha de mammiferes
WO2003014145A3 (fr) Peptides se liant avec les lesions atherosclereuses
WO2003063760A3 (fr) Peptides, anticorps diriges contre les maladies associees a l'amyloide et procedes utilisant ces peptides et ces anticorps en vue de diagnostiquer et de traiter ces maladies
EP1818062A3 (fr) Anticorps anti HSP90
WO2002072751A3 (fr) Polynucleotides codant une nouvelle metalloprotease, mp-1
BE1003316A5 (fr) Anticorps monoclonal utile pour le diagnostic de la maladie d'alzheimer, hybridome secreteur d'un tel anticorps monoclonal et procede pour sa preparation.
WO2003068813A3 (fr) Antigenes du streptocoque du groupe b
WO2002066606A3 (fr) Polynucleotides codant une nouvelle sous unite alpha du recepteur de glycine exprimee dans le tractus gastro-intestinal, hgra4, variant d'epissage de ce dernier
CA2072350A1 (fr) Polypeptides impliques dans l'expression de la resistance aux antibiotiques glycopeptidiques
WO2001023589A3 (fr) Nouvelle ubiquitine protease humaine nommee 23431
WO2001036605A3 (fr) 2786, nouvelle aminopeptidase humaine
WO2001000811A8 (fr) Nouvelle aminopeptidase humaine (17867)
ATE502046T1 (de) T-zellen-epitope des cyn-d-1-allergens aus bermudagraspollen
EP2163628A3 (fr) Polypeptides antigéniques de neisseria meningitidis, polynucléotides, et anticorps protecteurs correspondants
WO2002040654A3 (fr) Polynucleotide codant pour une nouvelle serpine humaine (lsi-01) secretee a partir des cellules lymphoides
WO2001032878A3 (fr) Phosphatonine: une nouvelle hormone polypeptidique
WO2001023590A3 (fr) La 22196, nouvelle aminopeptidase humaine
WO2005100555A3 (fr) NOUVEAUX VARIANTS AChE
WO2001090139A3 (fr) Ligand pour ameliorer l'administration d'agents biologiques par voie orale et via le systeme nerveux central

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2371675

Country of ref document: CA

Ref country code: CA

Ref document number: 2371675

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000931517

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000931517

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09980263

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2000931517

Country of ref document: EP